Market Tracker

09/01 5:52am ET

Ocata Therapeutics Inc (NASDAQ:OCAT)

4.23
Delayed Data
As of Aug 31
 +0.39 / +10.16%
Today’s Change
3.06
Today|||52-Week Range
12.73
-30.54%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close3.84
Today’s open3.87
Day’s range3.80 - 4.24
Volume517,600
Average volume (3 months)501,873
Market cap$162.1M
Dividend yield--
Data as of 08/31/2015

Growth & Valuation

Earnings growth (last year)-17.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-29.83%
P/E ratioNM
Price/Sales1,206.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDHLRedhill Biopharma Lt...+0.11+0.82%
BITIBiotie Therapies Oyj-0.08-0.47%
NEOTNeothetics Inc-0.14-1.17%
ABEOAbeona Therapeutics ...-0.15-3.11%
Data as of 08/31/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$157.9K
Annual profit (last year)-$34.7M
Net profit margin-22,010.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts